Cargando…
Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice
Alveolar echinococcosis (AE) caused by Echinococcus multilocularis is a chronic, progressive liver disease widely distributed in the Northern Hemisphere. The main treatment options include surgical interventions and chemotherapy with benzimidazole albendazole (ABZ). To improve the current diagnosis...
Autores principales: | Gómez, Cristina, Jebbawi, Fadi, Weingartner, Michael, Wang, Junhua, Stücheli, Simon, Stieger, Bruno, Gottstein, Bruno, Beldi, Guido, Lundström-Stadelmann, Britta, Odermatt, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307106/ https://www.ncbi.nlm.nih.gov/pubmed/34357336 http://dx.doi.org/10.3390/metabo11070442 |
Ejemplares similares
-
Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection
por: Weingartner, Michael, et al.
Publicado: (2022) -
Immunotherapy of alveolar echinococcosis via PD‐1/PD‐L1 immune checkpoint blockade in mice
por: Wang, Junhua, et al.
Publicado: (2018) -
Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014) -
Diagnostic and follow-up performance of serological tests for different forms/courses of alveolar echinococcosis
por: Gottstein, Bruno, et al.
Publicado: (2019) -
Accelerated Course of Alveolar Echinococcosis After Treatment With Steroids in a Patient With Autoimmune Encephalitis
por: Diem, Stefan, et al.
Publicado: (2021)